Results 221 to 230 of about 178,048 (244)
LSTM-driven drug design using SELFIES for target-focused de novo generation of HIV-1 protease inhibitor candidates for AIDS treatment. [PDF]
Albrijawi MT, Alhajj R.
europepmc +1 more source
ABSTRACT Aim To compare post‐operative pain following root canal treatment (RCT) in HIV‐positive patients receiving highly active antiretroviral therapy (HAART) and HIV‐negative patients and to assess the influence of systemic condition on endodontic pain.
Marcos Felipe Iparraguirre Nuñovero +5 more
wiley +1 more source
A Multifaceted Holistic Review of the Literature on Scar Dermatoses
ABSTRACT Many cutaneous diseases originate or manifest in scars. Scars are areas of compromised skin, which renders them a vulnerable cutaneous district for diseases to develop. The pathophysiology explaining why some dermatoses grow in scars is not yet thoroughly explored. The present study reviews the present literature on scar dermatoses.
Dana Maria Khoury +5 more
wiley +1 more source
This study reveals a tripartite pesticide–pathogen–host interaction in which the host kinase CDPK7‐like in Nicotiana benthamiana interacts with cucumber mosaic virus coat protein (CMV CP) to form LLPS‐driven condensates that facilitate viral infection.
Lei Zhao +7 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
HIV Protease: Historical Perspective and Current Research
Viruses, 2021Robert W Harrison, Irène T Weber
exaly
Inhibition of HIV‐2 Protease by HIV‐1 Protease Inhibitors in Clinical Use
Chemical Biology and Drug Design, 2008Ernesto Freire
exaly
Inhibitors of HIV-1 Protease by Using In Situ Click Chemistry
Angewandte Chemie - International Edition, 2006Hartmuth C Kolb +2 more
exaly

